Screener
Nuvation Bio NUVB EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss before income taxes | (62,840) | (59,007) | (57,443) | (112,243) |
| Provision for income taxes | — | — | — | — |
| Net loss | $(62,840) | $(59,007) | $(57,443) | $(112,243) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.18) | $(0.17) | $(0.17) | $(0.33) |
| Weighted average common shares outstanding, basic and diluted | 348,770 | 340,746 | 348,055 | 339,685 |
| Comprehensive loss: | ||||
| Net loss | $(62,840) | $(59,007) | $(57,443) | $(112,243) |
| Other comprehensive loss, net of taxes: |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's EPS (basic)?
- Nuvation Bio (NUVB) reported EPS (basic) of -$0.18 in Q2 2026.
- How has Nuvation Bio's EPS (basic) changed year-over-year?
- Nuvation Bio's EPS (basic) decreased by 5.9% year-over-year, from -$0.17 to -$0.18.
- What is the long-term trend for Nuvation Bio's EPS (basic)?
- Over 4 years (2021 to 2025), Nuvation Bio's EPS (basic) has grown at a 8.1% compound annual growth rate (CAGR), from -$0.44 to -$0.60.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.
Ask your AI about Nuvation Bio's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude